At the time of writing, West Pharmaceutical Services, Inc. [WST] stock is trading at $387.62, down -2.95%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The WST shares have gain 7.99% over the last week, with a monthly amount drifted -5.04%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, February 2024, West to Participate in Upcoming Investor Conferences. In a post published today on Yahoo Finance, West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024, at 1:05 PM ET.
From an analyst’s perspective:
West Pharmaceutical Services, Inc. [NYSE: WST] stock has seen the most recent analyst activity on February 07, 2024, when Jefferies upgraded its rating to a Buy and also boosted its price target to $536 from $323. Previously, BofA Securities upgraded its rating to Buy on June 16, 2023, and elevated its price target to $405. On April 11, 2023, upgrade upgraded it’s rating to Overweight and revised its price target to $400 on the stock. Deutsche Bank started tracking the stock assigning a Hold rating and suggested a price target of $250 on December 14, 2022. UBS initiated its recommendation with a Neutral and recommended $250 as its price target on November 30, 2022. BofA Securities downgraded its rating to Neutral for this stock on October 28, 2022, and downed its price target to $250. In a note dated November 10, 2020, KeyBanc Capital Markets initiated an Overweight rating and provided a target price of $350 on this stock.
For the past year, the stock price of West Pharmaceutical Services, Inc. fluctuated between $310.42 and $415.73. Currently, Wall Street analysts expect the stock to reach $250 within the next 12 months. West Pharmaceutical Services, Inc. [NYSE: WST] shares were valued at $387.62 at the most recent close of the market. An investor can expect a potential drop of -35.5% based on the average WST price forecast.
Analyzing the WST fundamentals
According to West Pharmaceutical Services, Inc. [NYSE:WST], the company’s sales were 2.95B for trailing twelve months, which represents an 3.35% jump. Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at 0.23%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.2%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.21 and Total Capital is 0.21. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 384.10 points at the first support level, and at 380.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 393.92, and for the 2nd resistance point, it is at 400.22.
West Pharmaceutical Services, Inc. [WST] reported earnings per share of $1.83 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $1.78/share, meaning a difference of $0.05 and a surprise factor of 2.80%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $2.16 per share as compared to estimates of $1.86 per share, a difference of $0.3 representing a surprise of 16.10%.
Ratios To Look Out For
It is important to note that West Pharmaceutical Services, Inc. [NYSE:WST] has a current ratio of 2.88. Further, the Quick Ratio stands at 2.24, while the Cash Ratio is 1.27. Considering the valuation of this stock, the price to sales ratio is 9.62, the price to book ratio is 9.89 and price to earnings (TTM) ratio is 49.22.
Transactions by insiders
Recent insider trading involved Winters Chad, VP, Chief Accounting Officer, that happened on Mar 11 ’24 when 815.0 shares were sold. VP & Treasurer, Witherspoon Charles completed a deal on Feb 28 ’24 to sell 2019.0 shares. Meanwhile, President, CEO and Board Chair Green Eric Mark sold 64132.0 shares on Feb 27 ’24.
